O Brien Greene & Co. Inc Takes Position in Healthequity Inc (NASDAQ:HQY)

O Brien Greene & Co. Inc acquired a new position in shares of Healthequity Inc (NASDAQ:HQY) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 3,400 shares of the company’s stock, valued at approximately $203,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in HQY. Morgan Stanley boosted its stake in shares of Healthequity by 15.5% during the 3rd quarter. Morgan Stanley now owns 4,001,425 shares of the company’s stock worth $377,775,000 after acquiring an additional 536,366 shares in the last quarter. Clearbridge Investments LLC raised its holdings in Healthequity by 976,643.6% during the third quarter. Clearbridge Investments LLC now owns 380,930 shares of the company’s stock valued at $35,964,000 after buying an additional 380,891 shares in the last quarter. Massachusetts Financial Services Co. MA bought a new position in Healthequity during the fourth quarter valued at about $15,455,000. Mirae Asset Global Investments Co. Ltd. bought a new position in Healthequity during the third quarter valued at about $19,021,000. Finally, Pictet Asset Management Ltd. bought a new position in Healthequity during the third quarter valued at about $18,882,000. 96.15% of the stock is owned by institutional investors and hedge funds.

HQY has been the topic of several recent research reports. Zacks Investment Research restated a “buy” rating and set a $66.00 target price on shares of Healthequity in a report on Monday, December 31st. BidaskClub lowered Healthequity from a “hold” rating to a “sell” rating in a report on Monday, January 7th. Citigroup set a $102.00 price objective on Healthequity and gave the stock a “buy” rating in a research note on Tuesday, January 8th. ValuEngine upgraded Healthequity from a “hold” rating to a “buy” rating in a research note on Monday, February 4th. Finally, SunTrust Banks upgraded Healthequity from a “hold” rating to a “buy” rating and set a $81.00 price objective on the stock in a research note on Thursday, February 7th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eleven have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $86.85.

HQY stock traded up $2.10 during trading on Friday, reaching $64.69. 1,128,001 shares of the stock were exchanged, compared to its average volume of 842,338. The company has a market cap of $4.04 billion, a PE ratio of 68.09, a price-to-earnings-growth ratio of 2.76 and a beta of 1.70. Healthequity Inc has a twelve month low of $50.29 and a twelve month high of $101.58.

Healthequity (NASDAQ:HQY) last released its quarterly earnings data on Monday, March 18th. The company reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.15 by $0.06. The company had revenue of $75.78 million for the quarter, compared to the consensus estimate of $74.28 million. Healthequity had a return on equity of 13.59% and a net margin of 25.73%. The company’s quarterly revenue was up 25.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.09 earnings per share. Research analysts predict that Healthequity Inc will post 0.94 EPS for the current fiscal year.

In other news, EVP Delano Ladd sold 6,875 shares of the business’s stock in a transaction that occurred on Wednesday, February 20th. The stock was sold at an average price of $78.00, for a total value of $536,250.00. Following the transaction, the executive vice president now directly owns 14,340 shares of the company’s stock, valued at approximately $1,118,520. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Darcy G. Mott sold 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 20th. The stock was sold at an average price of $77.87, for a total value of $311,480.00. Following the completion of the transaction, the vice president now directly owns 74,000 shares in the company, valued at $5,762,380. The disclosure for this sale can be found here. Insiders have sold 18,875 shares of company stock worth $1,429,370 over the last ninety days. Company insiders own 4.00% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “O Brien Greene & Co. Inc Takes Position in Healthequity Inc (NASDAQ:HQY)” was originally reported by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.baseballdailydigest.com/news/2019/04/21/o-brien-greene-co-inc-acquires-new-position-in-healthequity-inc-hqy.html.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Article: What is a Call Option?

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.